» Articles » PMID: 30602984

Molecular Surveillance of HCV Mono-infection and HCV-HBV Co-infection in Symptomatic Population at Hyderabad, Pakistan

Overview
Journal Afr Health Sci
Date 2019 Jan 4
PMID 30602984
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pakistan is endemic to hepatitis B and C infections. Alarming rise in hepatitis C virus (HCV) infection has been noticed in some areas of Sindh with an increasing risk for co-infection frequency in this region.

Objective: To estimate the burden of HBV/HCV infection in Hyderabad Pakistan.

Methods: ELISA and Nucleic acid Amplification test were performed to detect viruses. SPSS and online calculator were used for statistical analysis.

Results: From a total of 108 seropositive hepatitis patients, 36.1% (n=39) were found HCV RNA-positive. Non-significant differences were observed in the frequencies of HCV infection for both genders [OR=0.735, CI (95%) 0.307-1.761, p<0.05]. The percentage of HBV DNA detection among 108 HCV-seropositive cases was 17.9% (n=19). However, HCV-HBV co-infection in HCV-RNA positive cases was determined in 48.7% (n=19) cases with non-significant difference in both genders [OR=1.51, CI (95%) = 0.38 - 5.96, p< 0.05]. Analysis suggested weakly positive correlation between HCV mono-infection and HCV-HBV co-infection and age (r =0.184, and r =0.1231), respectively.

Conclusion: The study demonstrates a high prevalence of HBV co-infection among active hepatitis C patients of Hyderabad.

Citing Articles

Progress in infections, reproductive health and non-communicable diseases.

Tumwine J Afr Health Sci. 2019; 18(3):i-iv.

PMID: 30603019 PMC: 6306991. DOI: 10.4314/ahs.v18i3.1.

References
1.
Blakely T, Bates M, Baker M, Tobias M . Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand. Int J Epidemiol. 1999; 28(2):204-10. DOI: 10.1093/ije/28.2.204. View

2.
Andre F . Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000; 18 Suppl 1:S20-2. DOI: 10.1016/s0264-410x(99)00456-9. View

3.
Lavanchy D . Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2):97-107. DOI: 10.1046/j.1365-2893.2003.00487.x. View

4.
Liaw Y, Chen Y, Sheen I, Chien R, Yeh C, Chu C . Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology. 2004; 126(4):1024-9. DOI: 10.1053/j.gastro.2004.01.011. View

5.
Khokhar N, Gill M, Malik G . General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak. 2004; 14(9):534-6. DOI: 09.2004/JCPSP.534536. View